Document Type : Research Paper I Open Access I Released under CC BY-NC 4.0 license


1 Department of Exercise Physiology, Faculty of Physical Education and Sport Sciences, University of Tehran, Tehran, Iran.

2 Corresponding Author, Department of Physical Education and Sport Sciences, Marand Branch, Islamic Azad University, Marand, Iran.

3 Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.


Introduction: Doxorubicin (DOX) is an effective chemotherapy treatment for various cancers, but its use has been restricted due to cardiotoxicity effects. Studies about the protective effect of High-Intensity Interval Training (HIIT) against DOX-induced cardiotoxicity and its mechanisms are rare. This study aimed to investigate the protective effect of HIIT against the DOX-induced cardiotoxicity on the level of miR-499 expression which is widely expressed under the physiological conditions in the cardiomyocytes.
Methods: Twenty-four male Wistar rats were randomly assigned into four groups (n=6/group) including DOX (20 mg/kg body weight), HIIT (eight weeks, and seven 4-minutes sets of intervals at 80%–90% of VO2max interspersed with 3 minutes periods at 65%–75% of VO2max), HIIT+DOX and Control groups. The mRNA expression level was determined using the RT-PCR method. One-way analysis of variance followed by Tukey's post hoc test was used for statistical analysis of data (α<0.05).
Results: The results showed that DOX-induction significantly increased the MIR-499 expression in the left ventricular tissue of the rats’ heart (P<0.05). Also, the expression level of MIR-499 was increased after exercise, but this difference was not statistically significant. Exercise before the DOX-induction also led to a significant reduction of MIR-499 expression in the HIIT+ DOX group compared with the DOX group (P<0.05).
Conclusion: Therefore, performing HIIT before DOX induction can reduce the changes in MIR-499 expression caused by DOX. Therefore, HIIT could be a proper strategy for protecting the heart against DOX-induced cardiotoxicity by reducing MIR-499 expression.


Main Subjects

  1. Dolinsky VW, Rogan KJ, Sung MM, Zordoky BN, Haykowsky MJ, Young ME, et al. Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice. Am J Physiol Metab [Internet]. 2013 Jul 15;305(2):E243–53. Available from:
  2. Bartlett JJ, Trivedi PC, Yeung P, Kienesberger PC, Pulinilkunnil T. Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy. Biochem J [Internet]. 2016 Nov 1;473(21):3769–89. Available from:
  3. Chen JJ, Wu P-T, Middlekauff HR, Nguyen K-L. Aerobic exercise in anthracycline-induced cardiotoxicity: a systematic review of current evidence and future directions. Am J Physiol Circ Physiol [Internet]. 2017 Feb 1;312(2):H213–22. Available from:
  4. Koleini N, Kardami E. Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity. Oncotarget [Internet]. 2017 Jul 11;8(28):46663–80. Available from:
  5. MacFarlane L-A, R. Murphy P. MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics [Internet]. 2010 Nov 1;11(7):537–61. Available from:
  6. Condorelli G, Latronico MVG, Cavarretta E. microRNAs in cardiovascular diseases: current knowledge and the road ahead. J Am Coll Cardiol [Internet]. 2014 Jun;63(21):2177–87. Available from:
  7. Holmgren G, Synnergren J, Andersson CX, Lindahl A, Sartipy P. MicroRNAs as potential biomarkers for doxorubicin-induced cardiotoxicity. Toxicol Vitr [Internet]. 2016 Aug;34:26–34. Available from:
  8. Schroen B, Heymans S. MicroRNAs and beyond: The heart reveals its treasures. Hypertension [Internet]. 2009 Dec;54(6):1189–94. Available from:
  9. Liu J, Liang X, Zhou D, Lai L, Xiao L, Liu L, et al. Coupling of mitochondrial function and skeletal muscle fiber type by a miR‐499/Fnip1/ AMPK circuit. EMBO Mol Med [Internet]. 2016 Oct 9;8(10):1212–28. Available from:
  10. Wang J-X, Jiao J-Q, Li Q, Long B, Wang K, Liu J-P, et al. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat Med [Internet]. 2011 Jan 26;17(1):71–8. Available from:
  11. Olivieri F, Antonicelli R, Spazzafumo L, Santini G, Rippo MR, Galeazzi R, et al. Admission levels of circulating miR-499-5p and risk of death in elderly patients after acute non-ST elevation myocardial infarction. Int J Cardiol [Internet]. 2014 Mar;172(2):e276–8. Available from:
  12. Matkovich SJ, Hu Y, Eschenbacher WH, Dorn LE, Dorn GW. Direct and Indirect Involvement of MicroRNA-499 in Clinical and Experimental Cardiomyopathy. Circ Res [Internet]. 2012 Aug 17;111(5):521–31. Available from:
  13. Wang J, Jia Z, Zhang C, Sun M, Wang W, Chen P, et al. miR-499 protects cardiomyocytes from H 2 O 2 -induced apoptosis via its effects on Pdcd4 and Pacs2. RNA Biol [Internet]. 2014 Apr 27;11(4):339–50. Available from:
  14. Leger KJ, Leonard D, Nielson D, de Lemos JA, Mammen PPA, Winick NJ. Circulating microRNAs: Potential Markers of Cardiotoxicity in Children and Young Adults Treated With Anthracycline Chemotherapy. J Am Heart Assoc [Internet]. 2017 Apr 5;6(4). Available from:
  15. Kavazis AN, Smuder AJ, Powers SK. Effects of short-term endurance exercise training on acute doxorubicin-induced FoxO transcription in cardiac and skeletal muscle. J Appl Physiol [Internet]. 2014 Aug 1;117(3):223–30. Available from:
  16. Fathi Mohammad, Saeid Abroun. The effect of 14 weeks of endurance training on miR-499 expression of left ventricle in wistar male rat. J Sport Biosci. 2016;7(28). (In Persian).
  17. Villelabeitia-Jaureguizar K, Vicente-Campos D, Senen AB, Jiménez VH, Garrido-Lestache MEB, Chicharro JL. Effects of high-intensity interval versus continuous exercise training on post-exercise heart rate recovery in coronary heart-disease patients. Int J Cardiol [Internet]. 2017 Oct;244:17–23. Available from:
  18. Jarrett CL, D’Lugos AC, Mahmood TN, Gonzales RJ, Hale TM, Carroll CC, et al. Effect of High Intensity Exercise Preconditioning and Training on Antioxidant Enzymes in Cardiomyocytes During Doxorubicin Treatment. FASEB J. 2016;30(1).
  19. Okamoto A, Asai T, Ryu S, Ando H, Maeda N, Dewa T, et al. Enhanced Efficacy of Doxorubicin by microRNA-499-Mediated Improvement of Tumor Blood Flow. J Clin Med [Internet]. 2016 Jan 19;5(1):10. Available from:
  20. Høydal MA, Wisløff U, Kemi OJ, Ellingsen Ø. Running speed and maximal oxygen uptake in rats and mice: Practical implications for exercise training. Eur J Prev Cardiol. 2007;14(6):753–60.
  21. Asadi M, Shanehbandi D, Mohammadpour H, Hashemzadeh S, Sepehri B. Expression Level of miR-34a in Tumor Tissue from Patients with Esophageal Squamous Cell Carcinoma. J Gastrointest Cancer [Internet]. 2019 Jun 15;50(2):304–7. Available from:
  22. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res [Internet]. 2001 May 1;29(9):45e – 45. Available from:
  23. Vengatapathy KV, Ramesh R, Rajappa M, Kulkarni S, Hanifa M. Role of serum microRNA-499 as a diagnostic marker in acute myocardial infarction. Cor Vasa [Internet]. 2019 Jun 21;61(3):e272–6. Available from:
  24. D’Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG, et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J [Internet]. 2010 Nov;31(22):2765–73. Available from:
  25. Yang Y, Zhang H, Li X, Yang T, Jiang Q. Effects of PPARα/PGC-1α on the myocardial energy metabolism during heart failure in the doxorubicin induced dilated cardiomyopathy in mice. Int J Clin Exp Med. 2014;7(9):2435–42.
  26. Helgerud J, Høydal K, Wang E, Karlsen T, Berg P, Bjerkass M, et al. Aerobic High-Intensity Intervals Improve V˙O2max More Than Moderate Training. Med Sci Sport Exerc [Internet]. 2007 Apr;39(4):665–71. Available from:
  27. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, et al. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet. 2010;3(6):499–506.
  28. Marques-Aleixo I, Santos-Alves E, Torrella JR, Oliveira PJ, Magalhães J, Ascensão A. Exercise and Doxorubicin Treatment Modulate Cardiac Mitochondrial Quality Control Signaling. Cardiovasc Toxicol [Internet]. 2018 Feb 23;18(1):43–55. Available from:
  29. Ascensão A, Magalhães J, Soares JMC, Ferreira R, Neuparth MJ, Marques F, et al. Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis. Am J Physiol Circ Physiol [Internet]. 2005 Aug;289(2):H722–31. Available from: 01249.2004
  30. Rahimi M, Shekarforoush S, Asgari AR, Khoshbaten A, Rajabi H, Bazgir B, et al. The effect of high intensity interval training on cardioprotection against ischemia-reperfusion injury in wistar rats. EXCLI J. 2015;14:237–46.
  31. Jiang H-K, Wang Y-H, Sun L, He X, Zhao M, Feng Z-H, et al. Aerobic Interval Training Attenuates Mitochondrial Dysfunction in Rats Post-Myocardial Infarction: Roles of Mitochondrial Network Dynamics. Int J Mol Sci [Internet]. 2014 Mar 26;15(4):5304–22. Available from:
  32. Wisløff U, Støylen A, Loennechen JP, Bruvold M, Rognmo Ø, Haram PM, et al. Superior Cardiovascular Effect of Aerobic Interval Training Versus Moderate Continuous Training in Heart Failure Patients. Circulation [Internet]. 2007 Jun 19;115(24):3086–94. Available from: 106.675041
  33. Fu T, Wang C-H, Lin P-S, Hsu C-C, Cherng W-J, Huang S-C, et al. Aerobic interval training improves oxygen uptake efficiency by enhancing cerebral and muscular hemodynamics in patients with heart failure. Int J Cardiol [Internet]. 2013 Jul;167(1):41–50. Available from:
  34. Tjønna AE, Lee SJ, Rognmo Ø, Stølen TO, Bye A, Haram PM, et al. Aerobic Interval Training Versus Continuous Moderate Exercise as a Treatment for the Metabolic Syndrome. Circulation [Internet]. 2008 Jul 22;118(4):346–54. Available from: 108.772822
  35. Carvalho FS, Burgeiro A, Garcia R, Moreno AJ, Carvalho RA, Oliveira PJ. Doxorubicin-Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy. Med Res Rev [Internet]. 2014 Jan;34(1):106–35. Available from: https://onlinelibrary.wiley. com/doi/10.1002/med.21280
  36. Singal PK, Li T, Kumar D, Danelisen I, Iliskovic N. Adriamycin-induced heart failure: Mechanism and modulation. Mol Cell Biochem. 2000;207(1–2):77–86.